New medicines and technologies to improve outcomes
Recorded Monday 25th September | 08.30-13.00 CEST
From tissue engineering and organ reconditioning to nanorobotics, new technical and scientific advances look set to help organ shortages and compatibility become a thing of the past. Join us for a look into the future of transplantation as we review each of these exciting developments.
What you will see in this broadcast
08.30 - 09.10 CEST Breakfast session - Live from our studio
Gerrit Heijkoop and Stefan Schneeberger look forward to day 2 of the ESOT 2017 congress
Stefan Schneeberger talks to AST President Romina Danguilan about developments in Asia
Gerrit Heijkoop talks to Emma K. Massey about the EPAT tool
09.10 - 10.40 CEST | Organ Preservation and Enhancements - Live from the Auditorium
Gabriel Oniscu (Edinburgh, United Kingdom), presenting an overview of various technologies and clinical approaches to donor management that promise to improve the number of viable organs available for transplantation.
Peter Friend (Oxford, United Kingdom), presenting an update on the current state of ex situ organ reconditioning for the liver and other organs.
Nathaniel Hwang (Seoul, South Korea) discusses a fresh approach to tissue engineering, using scaffolds and human cell repopulation to aid in successful grafts.
Pablo Juan Ross (Davis, United States), discusses the gene editing techniques that have led to successful inter-species xenotransplantation, raising the possibility of human trials in the near future.
10.40 - 11.10 CEST Coffee session - Live from our studio
Our online host Gerrit Heijkoop introduces the Dubai hub and talks with Farhad Janahi who is there watching together with his colleagues
Gerrit Heijkoop talks with Gabriel Oniscu about donor management, following his speech at the plenary session
Gerrit Heijkoop talks with Pablo Juan Ross about his presentation at the State of the Art Session
11.10 - 12.40 CEST - Technology Enhanced Medicine - Live from the Auditorium
Angelo Lombardo (Milan, Italy), whose research into targeted genome editing through CRISPR/Cas techniques highlights an important advance that could significantly reduce the rate of organ rejection in transplant recipients.
Ellen Roche (Cambridge, United States), whose work in developing and prototyping novel cardiac devices – including a soft robotic heart sleeve for patients with heart failure, and a light reflecting balloon catheter for closing holes in the heart – holds promise for transplant patients.
Juan Carlos Izpisua Belmonte (La Jolla, USA) discussing new technologies that allow for differentiation of human cells inside embryos of different species, and new stem cell models and technologies that may help address ageing-related diseases in humans.
12.40 - 13.00 CEST Lunch session - Live from our studio
Gerrit Heijkoop talks with Wim Bens about the price for progress
Thomas Resch talks to Peter Friend about Ex-situ organ reconditioning